Konstantin Tachkov

921 total citations
58 papers, 380 citations indexed

About

Konstantin Tachkov is a scholar working on Economics and Econometrics, General Health Professions and Immunology. According to data from OpenAlex, Konstantin Tachkov has authored 58 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Economics and Econometrics, 9 papers in General Health Professions and 9 papers in Immunology. Recurrent topics in Konstantin Tachkov's work include Health Systems, Economic Evaluations, Quality of Life (21 papers), Pharmaceutical Economics and Policy (16 papers) and Biosimilars and Bioanalytical Methods (9 papers). Konstantin Tachkov is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (21 papers), Pharmaceutical Economics and Policy (16 papers) and Biosimilars and Bioanalytical Methods (9 papers). Konstantin Tachkov collaborates with scholars based in Bulgaria, Hungary and Netherlands. Konstantin Tachkov's co-authors include Guenka Petrova, Maria Kamusheva, Maria Dimitrova, Manoela Manova, Zoltán Kaló, Bertalan Németh, Nikolay Stoilov, Antal Zemplényi, Румен Стоилов and Wim Goettsch and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Konstantin Tachkov

48 papers receiving 372 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Konstantin Tachkov Bulgaria 11 89 49 48 46 44 58 380
Jay Visaria United States 10 89 1.0× 20 0.4× 38 0.8× 65 1.4× 60 1.4× 23 291
Masahiro Yasuda Japan 10 36 0.4× 59 1.2× 60 1.3× 38 0.8× 32 0.7× 55 394
Aamod Dhoj Shrestha Nepal 9 33 0.4× 48 1.0× 78 1.6× 33 0.7× 7 0.2× 13 557
A. Neiß Germany 13 102 1.1× 14 0.3× 11 0.2× 72 1.6× 13 0.3× 32 580
Victoria Hodgetts Morton United Kingdom 12 53 0.6× 89 1.8× 108 2.3× 13 0.3× 4 0.1× 50 628
Ana Hidalgo‐Simon Netherlands 9 99 1.1× 12 0.2× 24 0.5× 7 0.2× 6 0.1× 15 355
Jianing Yang China 14 71 0.8× 27 0.6× 69 1.4× 14 0.3× 2 0.0× 38 540
Mohammed Alassiri Saudi Arabia 15 40 0.4× 13 0.3× 91 1.9× 12 0.3× 3 0.1× 36 649
Thomas Senderovitz Denmark 12 32 0.4× 7 0.1× 75 1.6× 50 1.1× 8 0.2× 22 520
Krisy‐Ann Thornby United States 9 10 0.1× 20 0.4× 36 0.8× 57 1.2× 6 0.1× 26 253

Countries citing papers authored by Konstantin Tachkov

Since Specialization
Citations

This map shows the geographic impact of Konstantin Tachkov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Konstantin Tachkov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Konstantin Tachkov more than expected).

Fields of papers citing papers by Konstantin Tachkov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Konstantin Tachkov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Konstantin Tachkov. The network helps show where Konstantin Tachkov may publish in the future.

Co-authorship network of co-authors of Konstantin Tachkov

This figure shows the co-authorship network connecting the top 25 collaborators of Konstantin Tachkov. A scholar is included among the top collaborators of Konstantin Tachkov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Konstantin Tachkov. Konstantin Tachkov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Stoeva, Vera, et al.. (2023). Therapeutic Results and Survival of Patients with Myelofibrosis Treated with Ruxolitinib—A Real-Life Longitudinal Study. Cancers. 15(20). 5085–5085. 3 indexed citations
4.
5.
Tachkov, Konstantin, et al.. (2023). Cost-effectiveness of therapeutic drug monitoring (TDM) of biologic treatment in rheumatic diseases: a narrative review. Biotechnology & Biotechnological Equipment. 37(1). 1 indexed citations
6.
Németh, Bertalan, Maria Kamusheva, Antal Zemplényi, et al.. (2023). Guidance on using real-world evidence from Western Europe in Central and Eastern European health policy decision making. Journal of Comparative Effectiveness Research. 12(4). e220157–e220157. 2 indexed citations
7.
Stoeva, Vera, et al.. (2023). Study of Symptom Severity and Adherence to Therapy of Myelofibrosis Patients Treated with Ruxolitinib. Pharmaceuticals. 16(7). 976–976. 1 indexed citations
8.
9.
Zemplényi, Antal, Konstantin Tachkov, Bertalan Németh, et al.. (2023). Recommendations to overcome barriers to the use of artificial intelligence-driven evidence in health technology assessment. Frontiers in Public Health. 11. 1088121–1088121. 20 indexed citations
10.
Boyadzhieva, Vladimira, et al.. (2022). Quality of life and disease activity of patients with rheumatoid arthritis on tofacitinib and biologic disease-modifying antirheumatic drug therapies. Rheumatology International. 42(10). 1775–1783. 3 indexed citations
11.
Tachkov, Konstantin, et al.. (2022). Analysis of Healthcare Expenditures in Bulgaria. Healthcare. 10(2). 274–274. 6 indexed citations
12.
13.
Kamusheva, Maria, et al.. (2021). Pharmacotherapeutic Patterns and Patients’ Access to Pharmacotherapy for Some Rare Diseases in Bulgaria – A Pilot Comparative Study. Frontiers in Pharmacology. 12. 695181–695181. 1 indexed citations
14.
Kamusheva, Maria, Silvia Vandeva, Атанаска Еленкова, et al.. (2020). New Epidemiological, Clinical and Economic Data for Patients With Acromegaly in Bulgaria. Frontiers in Public Health. 8. 147–147. 16 indexed citations
15.
Tachkov, Konstantin, et al.. (2019). Micro and macro analysis on the burden of COPD hospitalizations on the Bulgarian healthcare system. Biotechnology & Biotechnological Equipment. 33(1). 1–11. 1 indexed citations
16.
Brodszky, Valentin, Petra Baji, Fanni Rencz, et al.. (2019). Cost-of-illness studies in nine Central and Eastern European countries. The European Journal of Health Economics. 20(S1). 155–172. 22 indexed citations
17.
Tachkov, Konstantin, et al.. (2019). Modeling the Pharmacotherapy Cost and Outcomes of Primary Open-Angle Glaucoma With Dry Eye. Frontiers in Public Health. 7. 363–363. 5 indexed citations
18.
19.
Tachkov, Konstantin, et al.. (2017). Social Burden of Copd. Value in Health. 20(9). A648–A649. 1 indexed citations
20.
Petrova, Guenka, et al.. (2015). Generics and fixed-dose combinations in cardiology: satisfaction analysis of pharmacists and cardiologists. SHILAP Revista de lepidopterología. 30(1). 204–211.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jay Visaria Breakdown of academic impact, for papers by Masahiro Yasuda Breakdown of academic impact, for papers by Aamod Dhoj Shrestha Breakdown of academic impact, for papers by A. Neiß Breakdown of academic impact, for papers by Victoria Hodgetts Morton Breakdown of academic impact, for papers by Ana Hidalgo‐Simon Breakdown of academic impact, for papers by Jianing Yang Breakdown of academic impact, for papers by Mohammed Alassiri Breakdown of academic impact, for papers by Thomas Senderovitz Breakdown of academic impact, for papers by Krisy‐Ann Thornby
Rankless by CCL
2026